Job title: Senior Vice President, Therapeutic Proteins
William Olson, PhD has 30 years of experience in the discovery and development of antibodies and other biologics. His efforts have resulted in the generation of dozens of novel agents that advanced into clinical testing. As Senior Vice President, Therapeutic Proteins, he currently leads a team dedicated to supplying the Regeneron pipeline with novel, fully human antibody-based therapies generated using the VelocImmuneTM mouse platform. Dr. Olson also spearheads initiatives on structural biology, chemistry and antibody-based imaging. His prior industry experience includes leadership positions at Progenics Pharmaceuticals and Johnson & Johnson. He received a Bachelor’s of Science degree from the University of North Dakota and a PhD in Biochemical Engineering from the Massachusetts Institute of Technology.
Leveraging VelocImmuneTM Technologies to Advance Development of Next-Generation Antibody Conjugates 4:30 pm
• Regeneron’s VeclociSuiteTM technologies enable rapid generation of large panels of novel fully human antibodies, bispecific antibodies and humanized mouse models • Reviewing these and other key technology platforms that provide powerful tools for generating and preclinically evaluating innovative antibody conjugates spanning diverse disease areas and therapeutic mechanisms of action • Outlining select examples that…Read more
day: Day Two